Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Cancer: 24-Month Results of the RSR1 Phase 1 Dose Escalation Study
- Resource Type
- Article
- Source
- In
Practical Radiation Oncology January-February 2023 13(1):e73-e79 - Subject
- Language
- ISSN
- 1879-8500